Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesDendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines
Expert Review of Vaccines, 09/02/09
Kataoka K et al. – The strategy of a DNA–based mucosal adjuvant facilitates the targeting of mucosal dendritic cells, and thus is an effective and safe approach. It would also provide great flexibility for the development of effective vaccines for various mucosal pathogens.
Related Articles
Effective vaginal DNA delivery with high transfection efficiency is a good system for induction of higher local vaginal immune responses
Journal of Pharmacy and Pharmacology, 11/18/09
Relevance Score: 65%
The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women
Journal of Reproductive Immunology, 11/06/09
Relevance Score: 65%
A Monoclonal IgG Antibody Directed against an Immunodominant Linear Epitope on the Ricin A Chain Confers Systemic and Mucosal Immunity to Ricin
Infection and Immunity, 10/29/09
Relevance Score: 65%
Vaccines and Microbicides Preventing HIV-1, HSV-2, and HPV Mucosal Transmission
Journal of Investigative Dermatology, 10/19/09
Relevance Score: 65%
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Relevance Score: 49%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09
Efficacy and Safety of Pentavalent Human-Bovine Reassortant Rotavirus Vaccine When Administered With Greater Than 10 Weeks Between Doses
The Pediatric Infectious Disease Journal, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor